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Medication Assisted Treatment for Opioid Use Disorder in the Primary Care Setting in 
Philadelphia: A Retrospective Review 
 
Introduction:  
 
The opioid crisis continues to be a growing public health concern across the United 
States. Americans struggling with Opioid Use Disorder (OUD) can seek different resources to 
help curtail their addiction. These include abstinence -based programs such as Narcotics 
Anonymous and Specialty treatment facilities including methadone and suboxone clinics. It has 
been shown that increased availability of drugs to treat opioid use addiction, such as methadone 
and buprenorphine, is linked to a lower likelihood of relapse and fatal overdoses. Therefore, 
medication assisted treatment (MAT) is a valuable asset because it combines behavioral therapy 
and medications to treat opioid use disorder. Despite the potential benefit of primary care MATs, 
there are factors leading to low access and utilization of these programs. They include limited 
number of trained prescribers, policy barriers such as insurance coverage, and both and provider 
stigma associated with MAT. Demographics from the MAT program of Project HOME Health 
Services of Philadelphia were reviewed for this project.  
 
Objective:  
 
To conduct a retrospective review of MAT program participant demographics at Project 
HOME Health Services in North Philadelphia. The goal is to identify the key demographics of 
patients enrolled in the program from July 2017- July 2018.   
 
Methods:  
 
 
 
A review of an Electronic Medical Record database from a population of 108 patients 
enrolled in the MAT program at Project HOME Health Services from July 2017-2018. The 
planned analysis is demographic descriptive statistics.  
 
Results:  
 
The age range of patients was 27-71. Of the 108 patients, 39 were considered active 
participants in the program (21 male, 18 female). Twenty-five percent of the patient population 
reported their homeless status as shelter, street, transitional, supportive housing, or formerly 
homeless. Sixty-nine patients received a hepatitis C virus antibody test, with 26 reporting results 
suggesting of a possible Hepatitis C, 8 positive, and 20 with negative testing. In the total 
population, there were 39% reported hypertension, 54% reported depression, and 94% reported 
current tobacco use. 
 
Conclusion:  
 The reported findings describe the demographics of the MAT participants of Project 
Home of Philadelphia. This data will be utilized in conjunction with other research that assesses 
adherence to MAT programs and quality of life.  Future areas for research involve statistical 
comparisons to determine factors leading to patient retention in the program. Another project 
would be to review the patients’ urine toxicology screens for additional information, including 
the number of months in the program until only the prescribed drugs are in the urine and how 
many drug screens were positive for fentanyl. Finally, further research may determine specific 
additional primary care needs of the participants.  
 
 
